New England Biolabs® Launches NEBNext® Enzymatic 5hmC-seq Kit, for enzyme-based 5hmC detection at single-base resolution

New bisulfite-free system allows scientists to accurately and sensitively discriminate 5hmC from un-modified cytosine and 5mC from a wide range of DNA inputs, advancing epigenetics research. IPSWICH, Mass., Feb. 13, 2024 /PRNewswire/ — New England Biolabs (NEB®) today announced the launch of the NEBNext Enzymatic 5hmC-seq Kit (E5hmC-seq™), a novel enzyme-based method for the specific … Read more

Meridian Bioscience Senior Director of R&D, Dr. Dan (Dror) Siman-Tov, to Spotlight Lateral Flow Innovations at the Advanced Lateral Flow Conference 2024

CINCINNATI, Feb. 12, 2024 /PRNewswire/ — Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, is proud to announce that Dr. Dan (Dror) Siman-Tov, Ph.D., MBA, Senior Director of R&D, Diagnostics, will be presenting at the Advanced Lateral Flow Conference 2024. The event is scheduled to take place at … Read more

INOVIO Reports Inducement Grant Under Inducement Plan

PLYMOUTH MEETING, Pa., Feb. 2, 2024 /PRNewswire/ — INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today announced that it has made an equity grant to a newly hired employee under its 2022 Inducement Plan (the “Inducement Plan”). The Compensation … Read more

Senhwa Biosciences Received Taiwan FDA IND Approval for Phase II Study of Silmitasertib in Patients with Community-Acquired Pneumonia (CAP) Associated with Viral Infection

TAIPEI and SAN DIEGO, Dec. 26, 2023 /PRNewswire/ — Senhwa Biosciences, Inc. (TPEx: 6492), a drug development company focusing on first-in-class therapeutics for oncology, rare diseases, and infectious diseases, announced today that Taiwan Food and Drug Administration has approved its Phase II IND application of Silmitasertib (CX-4945) to treat patients with community-acquired pneumonia (CAP) caused … Read more

Der aktualisierte, proteinbasierte COVID-19-Impfstoff von Novavax ist jetzt für alle 194 Mitgliedstaaten der Weltgesundheitsorganisation eine Option

GAITHERSBURG, Maryland, 28. November 2023 /PRNewswire/ — Novavax, Inc. (Nasdaq: NVAX), ein globales Unternehmen, das proteinbasierte Impfstoffe mit seinem Matrix-M™-Adjuvans voranbringt, gab heute bekannt, dass die Weltgesundheitsorganisation (WHO) eine Notfallzulassung (Emergency Use Listing, EUL) für den COVID-19-Impfstoff Nuvaxovid™ XBB.1.5 (NVX-CoV2601) für die aktive Immunisierung zur Vorbeugung gegen COVID-19 bei Personen ab 12 Jahren erhalten hat. Das … Read more

RECORD-BREAKING AND OLYMPIC DREAM-CHASING DAY AT THE CNO FINANCIAL INDIANAPOLIS MONUMENTAL MARATHON

INDIANAPOLIS, Oct. 28, 2023 /PRNewswire/ — The 16th annual CNO Financial Indianapolis Monumental Marathon, Half Marathon and 5K took place this morning in downtown Indianapolis in true monumental fashion, with nearly 15,000 athletes participating. The event was highlighted by three new course records and 19 athletes achieving the Olympic Team Trials – Marathon standard, unofficially. … Read more

Avidity Biosciences Announces New Positive AOC 1001 Data Demonstrating Improvement in Multiple Additional Functional Endpoints and Favorable Long-term Safety and Tolerability in People with Myotonic Dystrophy Type 1

New AOC 1001 data demonstrate improvement in additional functional measures including hand grip, muscle strength and patient reported outcomes, augmenting previously reported positive data showing improvements in myotonia, muscle strength and mobility   New long-term safety data of AOC 1001 continue to demonstrate favorable safety and tolerability with over 200 infusions totaling 46.2 patient-years of … Read more

Cano Health Files Preliminary Proxy Statement with the SEC to initiate plan for Reverse Stock Split

MIAMI, Oct. 5, 2023 /PRNewswire/ — Cano Health, Inc. (“Cano Health” or the “Company“) (NYSE: CANO) today announced that it has filed a preliminary proxy statement with the SEC regarding a special stockholders’ meeting to authorize Cano Health’s Board of Directors to effect a reverse stock split of the Company’s Class A and Class B common … Read more

Life Time Expands to Connecticut with First Athletic Country Club and Life Time Living Luxury Residences in Downtown Stamford

New village embraces Life Time’s ethos for healthy living with 62,000-square-foot athletic club and outdoor amenity deck, along with 290 luxury residences available for lease STAMFORD, Conn., Sept. 22, 2023 /PRNewswire/ — Life Time (NYSE:LTH), the nation’s premier healthy lifestyle brand, today opened its first athletic country club in Connecticut with a nearly 52,000-square foot … Read more

iNtRON Signs Bacteriophage Development Project with U.S. Army DEVCOM

Development of Bacteriophages targeting strains causing urinary tract infections Establishment of collaboration with the US Army and investigation of groundwork for entering the US defense market BOSTON and SEOUL, South Korea, Sept. 3, 2023 /PRNewswire/ — iNtRON Biotechnology (“iNtRON”, www.intodeworld.com) has announced today that its New Drug Part has entered into an official contract with the U.S. … Read more